To improve the quality, appropriateness, and effectiveness of diagnosis in health care, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The Improving Diagnosis in Medicine Act of 2024 creates a multi-pronged federal initiative to reduce diagnostic errors in healthcare. It establishes a research program at the Agency for Healthcare Research and Quality (AHRQ), creates diagnostic excellence research centers, expands fellowship and training opportunities, develops quality measures for diagnostic accuracy, convenes expert panels on data standardization, creates an interagency coordinating council, and commissions a National Academies report on diagnostic disparities.
Who Benefits and How
Patients benefit from improved diagnostic accuracy and reduced medical errors, which are a leading cause of harm in healthcare. Researchers and academic medical centers benefit from new funding streams totaling up to $45 million per year for diagnostic safety research. Healthcare providers benefit from better tools, training, and evidence-based practices for making accurate diagnoses. Underserved communities benefit from a specific focus on identifying and eliminating diagnostic disparities.
Who Bears the Burden and How
Federal taxpayers fund the program through authorized appropriations of $30-45 million annually for research (2025-2029), plus $1.5 million annually for the interagency council and $1.5 million for the National Academies study. Multiple federal agencies must dedicate personnel to serve on the interagency council. AHRQ bears the primary administrative burden of establishing and managing the new programs.
Key Provisions
- Authorizes $30-45 million annually (FY2025-2029) for a diagnostic safety research program at AHRQ
- Creates Research Centers of Diagnostic Excellence linking academic institutions with clinical practice
- Establishes an Interagency Council on Improving Diagnosis with members from CDC, CMS, VA, DOD, NIH, and other agencies
- Commissions a National Academies study on disparities in diagnostic safety across race, ethnicity, socioeconomic status, and other factors
- Expands Ruth Kirschstein fellowship awards to include diagnostic safety research
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Establishes a comprehensive federal program to improve diagnostic safety and quality in healthcare, including research funding, training grants, quality measure development, standardized data initiatives, an interagency council, and a National Academies report on diagnostic disparities.
Key Policy Areas
Healthcare, Science & Technology
Primary Purpose
Establishes a comprehensive federal program to improve diagnostic safety and quality in healthcare, including research funding, training grants, quality measure development, standardized data initiatives, an interagency council, and a National Academies report on diagnostic disparities.
Policy Domains
Whole Bill
Identified Gains
Contextual inference, no direct clause citation- Patients
- Healthcare researchers and academic medical centers
- Healthcare providers
- Underserved communities
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Federal taxpayers
- AHRQ
- Federal agencies on the interagency council
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMr. Beyer (for himself, Mr. Van Drew, and Ms. Schrier) …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Diagnostic research community, Healthcare research institutions, Medical researchers in diagnostic safety
AHRQ, Agency for Healthcare Research and Quality, HHS and participating agencies
Agency for Healthcare Research and Quality faces effects in multiple directions
Positive-direction: AHRQ
Negative-direction: HHS and participating agencies
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of the Agency for Healthcare Research and Quality (AHRQ)
- "the_secretary"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology